Gleevec

The Pharmalot View By Ed Silverman

Novartis, Colombia face off over cancer drug cost

Pharmalot By Ed Silverman

Colombia plans to unilaterally lower the cost of a Novartis cancer drug

Pharmalot By Ed Silverman

House Democrats blast US Trade Rep for pressuring Colombia over Novartis patent

Pharmalot By Ed Silverman

Colombian health minister is warned not to sidestep Novartis patent

Pharmalot By Ed Silverman

Colombian government recommendation puts Novartis cancer drug patent at jeopardy